Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedUpdated page to version v3.2.0 and added a government-operating-status notice; removed the Hb SS disease resource reference from v3.1.0.SummaryDifference4%

- Check28 days agoChange DetectedUpdate to v3.1.0 with a new mention of Hb SS disease, and removal of several general drug-safety and pharmaceutical terms, indicating a shift toward a more focused medical topic rather than broad safety content.SummaryDifference0.7%

- Check42 days agoChange DetectedUpdated the page to v3.0.2 by removing v3.0.1 and the 'Back to Top' element; this is a straightforward version update with a small UI cleanup.SummaryDifference0.2%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of topics related to drug safety and counterfeit drugs. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.